Nothing Special   »   [go: up one dir, main page]

WO2002022872A1 - Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method - Google Patents

Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method Download PDF

Info

Publication number
WO2002022872A1
WO2002022872A1 PCT/KR2001/001385 KR0101385W WO0222872A1 WO 2002022872 A1 WO2002022872 A1 WO 2002022872A1 KR 0101385 W KR0101385 W KR 0101385W WO 0222872 A1 WO0222872 A1 WO 0222872A1
Authority
WO
WIPO (PCT)
Prior art keywords
mycobacteria
oligonucleotide
seq
primers
multiplex pcr
Prior art date
Application number
PCT/KR2001/001385
Other languages
French (fr)
Inventor
Hee-Kyung Park
Hyun-Sook Park
Hyun-Jung Jang
Eun-Sil Song
Cheol-Min Kim
Original Assignee
Sjhightech Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sjhightech Co., Ltd. filed Critical Sjhightech Co., Ltd.
Priority to AU2001278813A priority Critical patent/AU2001278813A1/en
Publication of WO2002022872A1 publication Critical patent/WO2002022872A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Definitions

  • the present invention relates to a new multiplex polymerase chain reaction (PCR) method and a multiplex PCR kit and oligonucleotides for rapid and specific identification of Mycobacteria species, and more particularly, to a multiplex PCR method capable of detecting Mycobacteria genus and identifying M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species thereof in a single PCR using genus-specific and species-specific primers derived from the internal transcribed spacer (ITS) sequences of Mycobacteria.
  • PCR polymerase chain reaction
  • Mycobacteria are major pathogens causing human diseases. In the world, 800 million people are infected every year by Mycobacte um tuberculosis and 300 million people among them die from the infection (Raviglione, M. O, D. E. Snider, and A. Kochi, "Global epidemiology of tuberculosis, morbidity and mortality of a worldwide epidemic," JAMA, 271 :220-226, 1995). Recently, as the number of peoples suffering from AIDS rapidly increases, infections caused by non-tuberculosis Mycobacteria (NTM) are gradually increasing (Barnes, P., A. B. Bloch, P. T. Davidson, and D. E. Snider, "Jr.
  • NTM non-tuberculosis Mycobacteria
  • Bottger "Toward a phylogeny and definition of species at the molecular level within the genus Mycobactehum," Int. J. Syst Bacteriol., 40:323-30 (1990b); Rogall T., T. Flohr, and E. C. Bottger, "Differentiation of Mycobactehum species by direct sequencing of amplified DNA," J. Gen. Microbiol., 136 (Pt9):1915-1920 (1990a)).
  • the 16S rRNA gene has similar nucleotide sequences among some species, there is a limitation in identifying species to a certain extent (Fox, G. E., J. D. and P. J. Jurtshum, "How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity," Int. J. Syst. Bacteriol. 42: 166-170 (1992)).
  • IS6110 insertion element has multiple copy numbers in TB complexes of M. tuberculosis, M. africanum, M. bovis, and M. microti, and thus a PCR probe method using IS6110 as a target sequence is used.
  • Mycobactehum tuberculosis which do not have the IS6110 insertion element have been reported and thus may yield pseudo-negative test results (Yuen L. K., B. C. Ross, K. M. Jackson, and B. Dwyer, "Characterization of Mycobactehum tuberculosis strains from Vietnamese patients by Southern blot hybridization," J. Clin. Miclobiol., 31 :1615-1618 (1993)).
  • primers capable of amplifying the IS6110 insertion element and a detection kit therefor are commercially available as TB-PCR and TB Detection Kit (from Bioneer Co., Korea), application of these primers is restricted to certain species and the PCR kit can only detect the presence of TB complex.
  • NTM non-tuberculosis Mycobacteria
  • PCR polymerase chain reaction
  • PCR kit for use in the new PCR method in which detection of Mycobacteria genus and identification of M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species can be achieved at the same time through a single PCR using a minimum number of primers. It is a third object of the present invention to provide oligonucleotide primers for use in a new multiplex PCR method in which detection of Mycobacteria genus and identification of M. tuberculosis and non-tuberculosis Mycobacteria species can be achieved at the same time.
  • the first object of the present invention is achieved by a PCR method for simultaneously amplifying at least two target genes in a single tube through a single reaction using at least one oligonucleotide having a common sequence for the at least two target genes to be amplified, as a fixed primer(s), and at least two oligonucleotides each having gene-specific sequences as specific primers. It is preferable that the number of fixed primers is one and the number of specific primers is an integer from 2 to 6.
  • the second object of the present invention is achieved by a multiplex PCR kit comprising: at least one oligonucleotide having a common sequence for at least two target genes to be amplified, as a fixed phmer(s); and at least two oligonucleotides each having species-specific sequences as specific primers, wherein the fixed primer(s) and the specific primers are simultaneously reacted in a single tube.
  • the fixed primer is an oligonucleotide primer having a common sequence for Mycobacteria genus and the specific primers are oligonucleotide primers each having Mycobacteria species-specific sequences, such that identifying Mycobacteria and diagnosing infections caused by Mycobacteria are possible. More preferably, the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise at least two oligonucleotides having SEQ ID NOs. 2 through 6.
  • the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 3
  • detection of Mycobacteria genus and identification of M. tuberculosis can be achieved at the same time.
  • the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 6
  • detection of Mycobacteria genus and identification of M. avium can be achieved at the same time.
  • the specific primers comprise the oligonucleotides having SEQ ID NOs. 2, 3 and 6, detection of Mycobacteria genus and identification of M. tuberculosis or M. avium can be achieved at the same time.
  • the third object of the present invention is achieved by an oligonucleotide having SEQ ID NO. 1 for use in detecting Mycobacteria genus, an oligonucleotide having SEQ ID NO. 3 for use in identifying Mycobacterium tuberculosis, an oligonucleotide having SEQ ID NO. 4 for use in identifying Mycobacterium fortuitum as a non-tuberculosis Mycobacteria, an oligonucleotide having SEQ ID NO. 5 for use in identifying Mycobacterium flavescens as a non-tuberculosis Mycobacteria, and an oligonucleotide having SEQ NO. 6 for use in identifying Mycobacterium avium as a non-tuberculosis Mycobacteria.
  • FIG. 1 is a schematic representation of locations of the oligonucleotide primers used in a multiplex polymerase chain reaction (PCR) method according to the present invention, and a map of PCR amplification products;
  • PCR polymerase chain reaction
  • FIG. 2 shows an electrophoresis image taken after a PCR using genus-specific primers ITSF and MYC6 for Panmycobacteria;
  • FIG. 3 shows an electrophoresis image taken after a PCR using species-specific primers MTB10, FOR12, FLA9, and MAC5 for Mycobacteria
  • FIG. 4 shows an electrophoresis image taken after a multiplex PCR according to the present invention on a M. tuberculosis (MTB) and six non-tuberculosis Mycobacteria (NTM) using primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6
  • FIG. 5 is a schematic representation of the electrophoresis image of FIG. 4.
  • a multiplex polymerase chain reaction (PCR) method is developed for identifying Mycobacteria and diagnosing infections caused by the same, in which nucleotide sequences of an internal transcribed spacer (ITS) region between the 16S rRNA and 23S rRNA genes, which has genus- and species-specific sequences for Mycobacteria, are used as a target sequence.
  • ITS internal transcribed spacer
  • 23S rRNA genes which contain both conserved and polymorphic sequences for Mycobacteria, a genus-specific primer having the conserved sequence and species-specific primers having the polymorphic sequences are derived.
  • One conserved sequence region is used as a common reverse primer, and four species-specific primers combined with the one genus-specific primer are used as forward primers to obtain PCR products having different sizes.
  • M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species can be identified.
  • primers are designed such that PCR products obtained using the primers have different sizes for easy discrimination thereof by gel electrophoresis. All six primers are simultaneously applied to a single PCR to detect the Mycobacteria genus and identify M. tuberculosis and non-tuberculosis Mycobacteria species through the single PCR.
  • one primer pair is used for detection of one target strain.
  • 5 primer pairs i.e., 10 primers
  • the number of reactions required can be reduced by multiplex PCR, the number of primers required cannot be reduced even for the multiplex PCR.
  • the present inventor has researched to reduce the number of primers required to a minimum number and further develop primers having the same reaction conditions, which allows the primers to be simultaneously applied to the same PCR. As a result, detecting the Mycobacteria genus and identifying MTB and NTM species through a single PCR using only six primers can be realized.
  • the PCR primers according to the present invention are synthesized from an ITS sequence of Mycobacteria.
  • the multiplex PCR method according to the present invention for detecting the Mycobacteria genus and at the same time identifying MTB and NTM species through a single reaction uses six primers including species-specific forward primers and one common genus-specific reverse primer.
  • many restrictions are applied, such as ratios of A, G, C, and T of the primers, preventing formation of a dimer between the primers, and prohibiting three or more repetitions of the same sequence.
  • PCR conditions such as concentrations of template DNA, primers, dNTP, and Mg 2+ , reaction temperature, and reaction time, should be appropriate.
  • the reaction conditions should be further restricted when designing the primers.
  • the primers should be designed such that the amplification products have different sizes and can be distinguished from one another on a gel after the PCR.
  • PCR primers for use in detecting the Mycobacteria genus and identifying MTB and NTM species according to the present invention are designed to be appropriate for the multiplex PCR method. All six primers can be simultaneously applied to a single PCR, and thus the Mycobacteria genus can be detected and both MTB and NTM species can be identified through a single PCR with high sensitivity.
  • the PCR primers according to the present invention and the sizes of PCR products obtained using the primers are shown in Table 1 ,
  • the MYC6 (SEQ ID NO. 1 ) is the conversed sequence of Mycobacteria genus and its sense or antisense sequence can be used as a common reverse primer (fixed primer) in the present invention.
  • the ITSF (SEQ ID NO. 2) has the conserved sequence of the 16S RNA region, however is used as a specific primer in the present invention because it is a forward primer used for the detection of Mycobacteria.
  • the MTB10 (SEQ ID NO. 3), FOR12 (SEQ ID NO. 4), FLA9 (SEQ ID NO. 5) and MAC5 (SEQ ID NO. 6) are the specific sequences of MTB or NTM species and their sense or antisense sequences can be used as forward primers (specific primers) in the present invention.
  • FIG. 1 is a schematic representation of the map of amplification products from the multiplex PCR according to the present invention and locations of the primers used for the amplification.
  • Example 1 Incubation of Standard Mycobacteria Strains and Isolation of Genomic DNA
  • Standard strains of Mycobacteria were obtained from the Korean Collection for Type Culture (KCTC) and the American Type Culture Collection (ATCC). The DNA of these strains were isolated using InstaGene matrix (Bio-Rad Co.). 200 ⁇ l InstaGene matrix was put into a 1.5 ml tube. A target strain was incubated in a solid medium (Ogawa plate), one scrapping of the strain layer was removed with an inoculating loop and suspended in the InstaGene Matrix contained in the tube. The suspension was reacted at 56°C for 30 minutes and mixed thoroughly for 10 seconds. The mixture was heated at 100°C for 8 minutes and mixed thoroughly for 10 seconds. The mixture was centrifuged at 12,000 rpm for 3 minutes and the supernatant was collected as a template DNA for PCR.
  • KCTC Korean Collection for Type Culture
  • ATCC American Type Culture Collection
  • ITSF SEQ ID NO. 2
  • MYC6 SEQ ID NO. 1
  • FIG. 2 is an electrophoresis image taken after the PCR performed using primers ITSF and MYC6 derived from the Mycobacteria genus-specific sequence.
  • lane M represents an index of molecular weight of 100 basepair (bp)
  • lane C represents distilled water used as a negative control
  • lane 1 represents M. tuberculosis
  • lane 2 represents M. flavescens
  • lane 3 represents M. avium
  • lane 4 represents M. fortuitum
  • lane 5 represents M. kansasii
  • lane 6 represents M. chelonae
  • lane 7 represents M. szulgai. It is apparent from FIG. 2 that only Mycobacterium microorganisms are amplified through the PCR using the primers ITSF and MYC6.
  • FIG. 3 is an electrophoresis image taken after a PCR performed using species-specific primers MTB10, FOR12, FLA9, and MAC 5 derived from Mycobacteria species-specific sequences.
  • images A, B, C, and D are for M. tuberculosis, M. flavescene, M. avium, and M. fortuitum, respectively.
  • Lane M represents an index of molecular weight of 100 bp
  • lane C represents distilled water used as a negative control
  • lane 1 represents M. tuberculosis
  • lane 2 represents M. flavescens
  • lane 3 represents M. avium
  • lane 4 represents M. fortuitum
  • lane 5 represents M.
  • lane 6 represents M. chelonae
  • lane 7 represents M. szulgai.
  • image A M. tuberculosis
  • image B M. flavescens
  • image C M. avium
  • image D M. fortuitum
  • a multiplex PCR method was carried out for MTB and six NTM species using primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6 according to the present invention.
  • the reaction mixture contained 500 mM KCI, 100 mM Tris-HCI (pH 9.0), 1% Triton X-100, 2.5 mM each dNTP (dATP, dGTP, dTTP, and dCTP), 1.5 mM MgCI 2 , 1 U Taq DNA polymerase, a PCR enhancer, 10 pmols of each species-specific primer, and 30 pmols of the common reverse primer.
  • FIG. 4 is an electrophoresis image taken after the PCR performed for MTB and six NTM species using the primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6.
  • lane M represents an index of molecular weight of 100 bp
  • lane C represents distilled water used as a negative control
  • lane 1 represents M. tuberculosis
  • lane 2 represents M. flavescens
  • lane 3 represents M. avium
  • lane 4 represents M. fortuitum
  • lane 5 represents M. kansasii
  • lane 6 preresents M. chelonae
  • lane 7 represents M. szulgai.
  • FIG. 4 represents M. szulgai.
  • Mycrobacteria genus-specific amplification occurs in all lanes 1 through 7. Amplification of one MTB occurs in lane 1 , M. flavescens in lane 2, M. avium in lane 3, and M. fortuitum in lane 4. For. three NTMs, M. kansasii, M. chelonae, and M. szulgai, only Mycobacteria genus-specific amplification not specific to the species occurs.
  • FIG. 5 is a schematic representation of the electrophoresis image of FIG. 4.
  • bands 1 , 3, 5, 7, 9, 10 and 11 represent the PCR amplification products by the Mycobacteria genus-specific primer pair ITSF-MYC6, which is common for the species
  • band 2 represents the PCR amplification product by M.
  • primer pair MTB10-MYC6 band 4 represents the PCR amplification product by M. /7avesce/7ce-specific primer pair FLA9-MYC6, band 6 represents the PCR amplification product by M. awi/m-specific primer pair MAC5-MYC6, and band 8 represents M. fortuitum-spec ⁇ f)c primer pair FOR12-MYC6.
  • FIGS. 4 and 5 it is evident that species-specific amplification can occur in a single tube with a plurality of mixed primers.
  • the species-specific primers according to the present invention have the same PCR conditions and thus they can be simultaneously applied to a single PCR.
  • MTB and NTMs can be identified through a single multiplex PCR.
  • the present invention is described with reference to the penta-multiplex PCR method in which a plurality of bacteria species can be identified through a single PCR in one test tube using one fixed primer which is common for the genus, and five genus- and species-specific primers, the present invention can be applied to any type of multiplex PCR including di-, tri-, tetra-, and hexa-multiplex PCRs within the scope of the present invention.
  • the Mycobacteria genus and four kinds of MTB and NTM species can be identified at the same time through a single PCR in one test tube using a minimum number of primers.
  • the multiplex PCR method according to the present invention ensures rapid and accurate diagnosis at low costs without conducting other biochemical tests.
  • the multiplex PCR method according to the present invention can identify at least two species through a single method, and thus it can be efficiently applied for the diagnosis of tuberculosis.
  • the multiplex PCR method according to the present invention is effective in detecting NTM at low costs.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A new multiplex polymerase chain reaction (PCR) method and a multiplex PCR kit and oligonucleotides with which Mycobacteriay species can specifically and rapidly be identified based on the multiplex PCR method are provided. For the multiplex PCR method, at least two target genes are simultaneously amplified in a single tube through a single reaction using at least one oligonucleotide having a common sequence for the at least two target genes to be amplified, as a fixed primer(s), and at least two oligonucleotides each having gene-specific sequences as specific primers. The multiplex PCR kit uses an oligonucleotide primer having a conserved sequence of Mycobacteria as a fixed primer, and at least two oligonucleotide primers, which are specific to Mycobacteria species, as specific primers. Using this multiplex PCR kit, at least two Mycobacteria species can be identified through a single PCR. Thus, the multiplex PCR kit can be effectively applied in diagnosing M. tuberculosis and detecting non-tuberculosis Mycobacteria at low costs.

Description

MULTIPLEX PCR METHOD AND KIT AND OLIGONUCLEOTIDES FOR DETECTION AND IDENTIFICATION OF MYCOBACTERIA USING THE
MULTIPLEX PCR METHOD
Technical Field
The present invention relates to a new multiplex polymerase chain reaction (PCR) method and a multiplex PCR kit and oligonucleotides for rapid and specific identification of Mycobacteria species, and more particularly, to a multiplex PCR method capable of detecting Mycobacteria genus and identifying M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species thereof in a single PCR using genus-specific and species-specific primers derived from the internal transcribed spacer (ITS) sequences of Mycobacteria.
Background Art
Mycobacteria are major pathogens causing human diseases. In the world, 800 million people are infected every year by Mycobacte um tuberculosis and 300 million people among them die from the infection (Raviglione, M. O, D. E. Snider, and A. Kochi, "Global epidemiology of tuberculosis, morbidity and mortality of a worldwide epidemic," JAMA, 271 :220-226, 1995). Recently, as the number of peoples suffering from AIDS rapidly increases, infections caused by non-tuberculosis Mycobacteria (NTM) are gradually increasing (Barnes, P., A. B. Bloch, P. T. Davidson, and D. E. Snider, "Jr. Tuberculosis in patients with immunodeficiency virus infection," N. Engl. J. Med., 324:1644-1650, 1991 ). For this reason, there is an urgent need to develop a method for rapidly and efficiently identifying non-tuberculosis Mycobacteria as well as Mycobacte um tuberculosis and diagnosing infections caused by the same. Most conventional methods for identifying and classifying bacteria are based on the morphological, biochemical, and growth characteristics of bacteria. These conventional methods are very tedious and complicated to conduct and take much time. Due to these problems, use of a simple and rapid identification method using a gene as a target sequence becomes more common. For an emerging gene-based identification method, genus-specific or species-specific PCR primers or nucleotide probes are applied to a gene of interest.
Under this situation, pedigree analysis on Mycobacteria, which would provide the base for species identification, has been conducted by comparison of 16S rRNA or its nucleotide sequences. This is based on the fact that the16S rRNA gene has the conserved but polymorphic sequences for Mycobacteria species identification (Stahl, D. A., and J. W. Urbane, "The division between rapid and slow-growing species corresponds to natural relationships among the Mycobacteria," J. Bactehol., 172:116-124 (1990); Rogall, T., J. Wolters, T. Flohr, and E. C. Bottger, "Toward a phylogeny and definition of species at the molecular level within the genus Mycobactehum," Int. J. Syst Bacteriol., 40:323-30 (1990b); Rogall T., T. Flohr, and E. C. Bottger, "Differentiation of Mycobactehum species by direct sequencing of amplified DNA," J. Gen. Microbiol., 136 (Pt9):1915-1920 (1990a)). However, since the 16S rRNA gene has similar nucleotide sequences among some species, there is a limitation in identifying species to a certain extent (Fox, G. E., J. D. and P. J. Jurtshum, "How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity," Int. J. Syst. Bacteriol. 42: 166-170 (1992)).
Also, IS6110 insertion element has multiple copy numbers in TB complexes of M. tuberculosis, M. africanum, M. bovis, and M. microti, and thus a PCR probe method using IS6110 as a target sequence is used. However, Mycobactehum tuberculosis which do not have the IS6110 insertion element have been reported and thus may yield pseudo-negative test results (Yuen L. K., B. C. Ross, K. M. Jackson, and B. Dwyer, "Characterization of Mycobactehum tuberculosis strains from Vietnamese patients by Southern blot hybridization," J. Clin. Miclobiol., 31 :1615-1618 (1993)). Although primers capable of amplifying the IS6110 insertion element and a detection kit therefor are commercially available as TB-PCR and TB Detection Kit (from Bioneer Co., Korea), application of these primers is restricted to certain species and the PCR kit can only detect the presence of TB complex.
As infections caused by non-tuberculosis Mycobacteria (NTM), and particularly by unidentified new species of NTM, are increasing, there is a need for the development of a new species-specific sequence-based identification and diagnosis method so as to accurately identify disease causing species to prevent and remedy infections caused by new species of NTM.
Disclosure of the Invention
To solve the above-described problems, it is a first object of the present invention to provide a multiplex polymerase chain reaction (PCR) method capable of amplifying at least two target genes in a single PCR using a minimum number of primers. It is a second object of the present invention to provide a multiplex
PCR kit for use in the new PCR method in which detection of Mycobacteria genus and identification of M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species can be achieved at the same time through a single PCR using a minimum number of primers. It is a third object of the present invention to provide oligonucleotide primers for use in a new multiplex PCR method in which detection of Mycobacteria genus and identification of M. tuberculosis and non-tuberculosis Mycobacteria species can be achieved at the same time. The first object of the present invention is achieved by a PCR method for simultaneously amplifying at least two target genes in a single tube through a single reaction using at least one oligonucleotide having a common sequence for the at least two target genes to be amplified, as a fixed primer(s), and at least two oligonucleotides each having gene-specific sequences as specific primers. It is preferable that the number of fixed primers is one and the number of specific primers is an integer from 2 to 6.
The second object of the present invention is achieved by a multiplex PCR kit comprising: at least one oligonucleotide having a common sequence for at least two target genes to be amplified, as a fixed phmer(s); and at least two oligonucleotides each having species-specific sequences as specific primers, wherein the fixed primer(s) and the specific primers are simultaneously reacted in a single tube. It is preferable that for the multiplex PCR kit, the fixed primer is an oligonucleotide primer having a common sequence for Mycobacteria genus and the specific primers are oligonucleotide primers each having Mycobacteria species-specific sequences, such that identifying Mycobacteria and diagnosing infections caused by Mycobacteria are possible. More preferably, the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise at least two oligonucleotides having SEQ ID NOs. 2 through 6.
For example, when the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 3, detection of Mycobacteria genus and identification of M. tuberculosis can be achieved at the same time. When the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 6, detection of Mycobacteria genus and identification of M. avium can be achieved at the same time. When the specific primers comprise the oligonucleotides having SEQ ID NOs. 2, 3 and 6, detection of Mycobacteria genus and identification of M. tuberculosis or M. avium can be achieved at the same time.
The third object of the present invention is achieved by an oligonucleotide having SEQ ID NO. 1 for use in detecting Mycobacteria genus, an oligonucleotide having SEQ ID NO. 3 for use in identifying Mycobacterium tuberculosis, an oligonucleotide having SEQ ID NO. 4 for use in identifying Mycobacterium fortuitum as a non-tuberculosis Mycobacteria, an oligonucleotide having SEQ ID NO. 5 for use in identifying Mycobacterium flavescens as a non-tuberculosis Mycobacteria, and an oligonucleotide having SEQ NO. 6 for use in identifying Mycobacterium avium as a non-tuberculosis Mycobacteria.
Brief Description of the Drawings
FIG. 1 is a schematic representation of locations of the oligonucleotide primers used in a multiplex polymerase chain reaction (PCR) method according to the present invention, and a map of PCR amplification products;
FIG. 2 shows an electrophoresis image taken after a PCR using genus-specific primers ITSF and MYC6 for Panmycobacteria;
FIG. 3 shows an electrophoresis image taken after a PCR using species-specific primers MTB10, FOR12, FLA9, and MAC5 for Mycobacteria; FIG. 4 shows an electrophoresis image taken after a multiplex PCR according to the present invention on a M. tuberculosis (MTB) and six non-tuberculosis Mycobacteria (NTM) using primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6; and FIG. 5 is a schematic representation of the electrophoresis image of FIG. 4.
Best mode for carrying out the Invention
According to the present invention, a multiplex polymerase chain reaction (PCR) method is developed for identifying Mycobacteria and diagnosing infections caused by the same, in which nucleotide sequences of an internal transcribed spacer (ITS) region between the 16S rRNA and 23S rRNA genes, which has genus- and species-specific sequences for Mycobacteria, are used as a target sequence. In other words, from the ITS region between the 16S rRNA and
23S rRNA genes, which contain both conserved and polymorphic sequences for Mycobacteria, a genus-specific primer having the conserved sequence and species-specific primers having the polymorphic sequences are derived. One conserved sequence region is used as a common reverse primer, and four species-specific primers combined with the one genus-specific primer are used as forward primers to obtain PCR products having different sizes. As a result, the Mycobacteria genus can be detected and at the same time M. tuberculosis (MTB) and non-tuberculosis Mycobacteria (NTM) species can be identified.
These primers are designed such that PCR products obtained using the primers have different sizes for easy discrimination thereof by gel electrophoresis. All six primers are simultaneously applied to a single PCR to detect the Mycobacteria genus and identify M. tuberculosis and non-tuberculosis Mycobacteria species through the single PCR.
In general, one primer pair is used for detection of one target strain. Thus, 5 primer pairs, i.e., 10 primers, are required to detect five targets through five separate PCRs. Although the number of reactions required can be reduced by multiplex PCR, the number of primers required cannot be reduced even for the multiplex PCR. In this aspect, the present inventor has researched to reduce the number of primers required to a minimum number and further develop primers having the same reaction conditions, which allows the primers to be simultaneously applied to the same PCR. As a result, detecting the Mycobacteria genus and identifying MTB and NTM species through a single PCR using only six primers can be realized.
The PCR primers according to the present invention are synthesized from an ITS sequence of Mycobacteria. The multiplex PCR method according to the present invention for detecting the Mycobacteria genus and at the same time identifying MTB and NTM species through a single reaction uses six primers including species-specific forward primers and one common genus-specific reverse primer. When designing the primers, many restrictions are applied, such as ratios of A, G, C, and T of the primers, preventing formation of a dimer between the primers, and prohibiting three or more repetitions of the same sequence. In addition, PCR conditions, such as concentrations of template DNA, primers, dNTP, and Mg2+, reaction temperature, and reaction time, should be appropriate.
For the multiplex PCR method according to the present invention for detecting the Mycobacteria genus and identifying both MTB and NTM species through a single reaction by combination of appropriate primers, the reaction conditions should be further restricted when designing the primers. In addition, the primers should be designed such that the amplification products have different sizes and can be distinguished from one another on a gel after the PCR.
Six primers for use in detecting the Mycobacteria genus and identifying MTB and NTM species according to the present invention are designed to be appropriate for the multiplex PCR method. All six primers can be simultaneously applied to a single PCR, and thus the Mycobacteria genus can be detected and both MTB and NTM species can be identified through a single PCR with high sensitivity. The PCR primers according to the present invention and the sizes of PCR products obtained using the primers are shown in Table 1 ,
Table 1
Figure imgf000008_0001
Figure imgf000009_0001
The MYC6 (SEQ ID NO. 1 ) is the conversed sequence of Mycobacteria genus and its sense or antisense sequence can be used as a common reverse primer (fixed primer) in the present invention. The ITSF (SEQ ID NO. 2) has the conserved sequence of the 16S RNA region, however is used as a specific primer in the present invention because it is a forward primer used for the detection of Mycobacteria. The MTB10 (SEQ ID NO. 3), FOR12 (SEQ ID NO. 4), FLA9 (SEQ ID NO. 5) and MAC5 (SEQ ID NO. 6) are the specific sequences of MTB or NTM species and their sense or antisense sequences can be used as forward primers (specific primers) in the present invention.
FIG. 1 is a schematic representation of the map of amplification products from the multiplex PCR according to the present invention and locations of the primers used for the amplification.
The present invention will be described in greater detail by means of the following examples. The following examples are for illustrative purposes and are not intended to limit the scope of the invention.
Example 1 : Incubation of Standard Mycobacteria Strains and Isolation of Genomic DNA
Standard strains of Mycobacteria were obtained from the Korean Collection for Type Culture (KCTC) and the American Type Culture Collection (ATCC). The DNA of these strains were isolated using InstaGene matrix (Bio-Rad Co.). 200 μl InstaGene matrix was put into a 1.5 ml tube. A target strain was incubated in a solid medium (Ogawa plate), one scrapping of the strain layer was removed with an inoculating loop and suspended in the InstaGene Matrix contained in the tube. The suspension was reacted at 56°C for 30 minutes and mixed thoroughly for 10 seconds. The mixture was heated at 100°C for 8 minutes and mixed thoroughly for 10 seconds. The mixture was centrifuged at 12,000 rpm for 3 minutes and the supernatant was collected as a template DNA for PCR.
The standard strains used were:
M. tuberculosis H37Rv (ATCC 27294)
M. fortuitum (ATCC 6841 )
M. flavescens (ATCC 14474)
M. avium (ATCC 25291 ) M. kansasii (ATCC 12478)
M. chelonae (ATCC 35752)
M. szulgai (ATCC 35799)
Example 2: Preparation of Primers and Probes for use in PCR 1 ) Preparation of primers and probes for detection of
Mycobacteria gene
As primers capable of amplifying only Mycobacteria gene, not other pathogenic microorganisms, conserved sequences existing in all
Mycobacteria were chosen. ITSF (SEQ ID NO. 2) as a forward primer and MYC6 (SEQ ID NO. 1 ) as a reverse primer were prepared by well-known methods.
2) Preparation of Primers and Probes for identification of MTB species As primers capable of specifically amplifying MTB, MTB 10 (SEQ
ID NO. 3) as a forward primer and MYC6 (SEQ ID NO. 1 ) as a reverse primer were prepared from the sequences of the ITS region of MTB.
3) Preparation of Primers and Probes for identification of NTM species As NTM-specific primers capable of amplifying each NTM species into amplification products having different sizes for easy separation on a gel after the reaction, FOR12 (SEQ ID NO. 4), FLA9 (SEQ ID NO. 5), and MAC5 (SEQ ID NO. 6) as forward primers, and MYC6 (SEQ ID. NO. 1 ) as a reverse primer were prepared from the sequence of the ITS region of NTM.
Example 3: Primer Specificity Test
Prior to application of the multiplex PCR to the standard Mycobacteria strains, separate PCRs were carried out on various strains including four target strains using each of the prepared primers. After sufficient denaturation at 94°C for 5 minutes, 40 cycles of amplification at 94°C for 1 minute, at 64°C for 1 minutes, and at 72°C for 1 minute were carried out and followed by a single final extension at 72°C for 10 minutes. After the reaction, the reaction products were analyzed by electrophoresis on a 3% agarose gel.
FIG. 2 is an electrophoresis image taken after the PCR performed using primers ITSF and MYC6 derived from the Mycobacteria genus-specific sequence. In FIG. 2, lane M represents an index of molecular weight of 100 basepair (bp), lane C represents distilled water used as a negative control, lane 1 represents M. tuberculosis, lane 2 represents M. flavescens, lane 3 represents M. avium, lane 4 represents M. fortuitum, lane 5 represents M. kansasii, lane 6 represents M. chelonae, and lane 7 represents M. szulgai. It is apparent from FIG. 2 that only Mycobacterium microorganisms are amplified through the PCR using the primers ITSF and MYC6.
FIG. 3 is an electrophoresis image taken after a PCR performed using species-specific primers MTB10, FOR12, FLA9, and MAC 5 derived from Mycobacteria species-specific sequences. In FIG. 3, images A, B, C, and D are for M. tuberculosis, M. flavescene, M. avium, and M. fortuitum, respectively. Lane M represents an index of molecular weight of 100 bp, lane C represents distilled water used as a negative control, lane 1 represents M. tuberculosis, lane 2 represents M. flavescens, lane 3 represents M. avium, lane 4 represents M. fortuitum, lane 5 represents M. kansasii, lane 6 represents M. chelonae, and lane 7 represents M. szulgai. As shown in FIG. 3, it is apparent that amplification of M. tuberculosis (image A) occurs only in lane 1 , M. flavescens (image B) only in lane 2, M. avium (image C) only in lane 3, and M. fortuitum (image D) only in lane 4.
Example 4: Multiplex PCR Method for Standard Strains
A multiplex PCR method was carried out for MTB and six NTM species using primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6 according to the present invention. The reaction mixture contained 500 mM KCI, 100 mM Tris-HCI (pH 9.0), 1% Triton X-100, 2.5 mM each dNTP (dATP, dGTP, dTTP, and dCTP), 1.5 mM MgCI2, 1 U Taq DNA polymerase, a PCR enhancer, 10 pmols of each species-specific primer, and 30 pmols of the common reverse primer. After sufficient denaturation at 94°C for 5 minutes, 40 cycles of amplification at 94°C for 1 minute, at 64°C for 1 minutes, and at 72°C for 1 minute were carried out and followed by a single final extension at 72°C for 10 minutes. After the reaction, the reaction products were analyzed by electrophoresis on a 3% agarose gel.
FIG. 4 is an electrophoresis image taken after the PCR performed for MTB and six NTM species using the primers ITSF, MTB10, FOR12, FLA9, MAC5, and MYC6. In FIG. 4, lane M represents an index of molecular weight of 100 bp, lane C represents distilled water used as a negative control, lane 1 represents M. tuberculosis, lane 2 represents M. flavescens, lane 3 represents M. avium, lane 4 represents M. fortuitum, lane 5 represents M. kansasii, lane 6 preresents M. chelonae, and lane 7 represents M. szulgai. As shown in FIG. 4, Mycrobacteria genus-specific amplification occurs in all lanes 1 through 7. Amplification of one MTB occurs in lane 1 , M. flavescens in lane 2, M. avium in lane 3, and M. fortuitum in lane 4. For. three NTMs, M. kansasii, M. chelonae, and M. szulgai, only Mycobacteria genus-specific amplification not specific to the species occurs.
FIG. 5 is a schematic representation of the electrophoresis image of FIG. 4. In FIG. 5, bands 1 , 3, 5, 7, 9, 10 and 11 represent the PCR amplification products by the Mycobacteria genus-specific primer pair ITSF-MYC6, which is common for the species, band 2 represents the PCR amplification product by M.
Figure imgf000012_0001
primer pair MTB10-MYC6, band 4 represents the PCR amplification product by M. /7avesce/7ce-specific primer pair FLA9-MYC6, band 6 represents the PCR amplification product by M. awi/m-specific primer pair MAC5-MYC6, and band 8 represents M. fortuitum-spec\f)c primer pair FOR12-MYC6. As shown in FIGS. 4 and 5, it is evident that species-specific amplification can occur in a single tube with a plurality of mixed primers.
The species-specific primers according to the present invention have the same PCR conditions and thus they can be simultaneously applied to a single PCR. Thus, by the multiplex PCR according to the present invention which uses the six primers at the same time, MTB and NTMs can be identified through a single multiplex PCR.
Although the present invention is described with reference to the penta-multiplex PCR method in which a plurality of bacteria species can be identified through a single PCR in one test tube using one fixed primer which is common for the genus, and five genus- and species-specific primers, the present invention can be applied to any type of multiplex PCR including di-, tri-, tetra-, and hexa-multiplex PCRs within the scope of the present invention.
Industrial Applicability As described above, in the multiplex PCR method according to the present invention, the Mycobacteria genus and four kinds of MTB and NTM species can be identified at the same time through a single PCR in one test tube using a minimum number of primers. The multiplex PCR method according to the present invention ensures rapid and accurate diagnosis at low costs without conducting other biochemical tests. The multiplex PCR method according to the present invention can identify at least two species through a single method, and thus it can be efficiently applied for the diagnosis of tuberculosis. In addition, the multiplex PCR method according to the present invention is effective in detecting NTM at low costs.

Claims

What is claimed is:
• 1. A multiplex polymerase chain reaction (PCR) method for simultaneously amplifying at least two target genes in a single tube through a single reaction using at least one oligonucleotide having a common sequence for the at least two target genes to be amplified, as a fixed primer(s), and at least two oligonucleotides each having gene-specific sequences as specific primers.
2. The multiplex PCR method of claim 1 , wherein the number of fixed primers is one and the number of specific primers is an integer from 2 to 6.
3. A multiplex polymerase chain reaction (PCR) kit comprising: at least one oligonucleotide having a common sequence for at least two target genes to be amplified, as a fixed primer(s); and at least two oligonucleotides each having gene-specific sequences as specific primers, wherein the fixed primer(s) and the specific primers are simultaneously reacted in a single tube.
4. The multiplex PCR kit of claim 3 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer is an oligonucleotide primer having a common sequence for Mycobacteria genus and the specific primers are oligonucleotide primers each having Mycobacteria species-specific sequences.
5. The multiplex PCR kit of claim 3 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer is a genus-specific primer having a conserved sequence derived from an internal transcribed spacer (ITS) between 16S rRNA and 23S rRNA of a Mycobacteria genus and the specific primers are species-specific primers having a polymorphic sequence derived from the ITS between 16S rRNA and 23S rRNA.
6. The multiplex PCR kit of claim 3 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise at least two oligonucleotides having SEQ ID NOs. 2 through 6.
7. The multiplex PCR kit of claim 6 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 3.
8. The multiplex PCR kit of claim 6 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise the oligonucleotides having SEQ ID NOs. 2 and 6.
9. The multiplex PCR kit of claim 6 for identifying Mycobacteria and diagnosing infections caused by Mycobacteria, wherein the fixed primer comprises the oligonucleotide having SEQ ID NO. 1 and the specific primers comprise the oligonucleotides having SEQ ID NOs. 2, 3 and 6.
10. An oligonucleotide having SEQ ID NO. 1 for use in detecting Mycobacteria.
11. An oligonucleotide having SEQ ID NO. 3 for use in identifying Mycobacterium tuberculosis.
12. An oligonucleotide having SEQ ID NO. 4 for use in identifying Mycobactehum fortuitum as a non-tuberculosis Mycobacteria.
13. An oligonucleotide having SEQ ID NO. 5 for use in identifying Mycobactehum flavescens as a non-tuberculosis
Mycobacteria.
14. An oligonucleotide having SEQ NO. 6 for use in identifying Mycobacterium avium as a non-tuberculosis Mycobacteria.
PCT/KR2001/001385 2000-09-15 2001-08-14 Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method WO2002022872A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001278813A AU2001278813A1 (en) 2000-09-15 2001-08-14 Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0054166A KR100433260B1 (en) 2000-09-15 2000-09-15 Multiplex pcr, kit and oligonucleotide for detection and identification of mycobacteria using multiplex pcr
KR2000/54166 2000-09-15

Publications (1)

Publication Number Publication Date
WO2002022872A1 true WO2002022872A1 (en) 2002-03-21

Family

ID=19688740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2001/001385 WO2002022872A1 (en) 2000-09-15 2001-08-14 Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method

Country Status (3)

Country Link
KR (1) KR100433260B1 (en)
AU (1) AU2001278813A1 (en)
WO (1) WO2002022872A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215238C1 (en) * 2002-04-06 2003-08-14 Cytonet Gmbh & Co Kg Detecting mycobacteria and differentiating between Mycobacterium tuberculosis and Mycobacterium avium, comprises amplifying the 16S rRNA gene
WO2003080871A2 (en) 2002-03-26 2003-10-02 Hain Lifescience Gmbh Method for detection and differentiation of mycobacterium tuberculosis complex
EP1431400A2 (en) * 2002-12-19 2004-06-23 Tosoh Corporation Method of detecting acid-fast bacteria using ribosomal RNA as target
WO2005056831A1 (en) * 2003-12-03 2005-06-23 Council Of Scientific And Industrial Research Method for detecting pathogenic mycobacteria in clinical specimens
US7332597B2 (en) 2004-06-28 2008-02-19 University Of Kentucky Research Foundation Primers and probe to identify mycobacterium tuberculosis complex
EP2270202A1 (en) * 2009-07-03 2011-01-05 John Ikonomopoulos Mycobacterial detection
JP2013502922A (en) * 2009-08-26 2013-01-31 エルジー ライフ サイエンス リミテッド M.M. A composition for detecting the M. TUBERCULOSIS group and the genus MYCOBACTERIA, and multiplex real-time PCR using the same composition, M. tuberculosis group. A method for simultaneously detecting the M. TUBERCULOSIS group and the genus MYCOBACTERIA
CN103555828A (en) * 2013-10-10 2014-02-05 上海市肺科医院 Rapid detection method and detection target for drug sensitivity of mycobacteria
WO2014164094A1 (en) * 2013-03-11 2014-10-09 Kailos Genetics, Inc. Capture methodologies for circulating cell free dna
CN109975543A (en) * 2019-03-01 2019-07-05 中国疾病预防控制中心传染病预防控制所 The application of mycobacteria Ku albumen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100446850B1 (en) * 2001-07-19 2004-09-04 이혜영 A method for identifying Micobacteria tuberculosis and non-tuberculosis Micobacteria, together with detecting resistance to an antituberculsis drug of Micobacteria obtained by mutation of rpoB gene
KR100454585B1 (en) * 2001-10-09 2004-11-02 주식회사 에스제이하이테크 Microarray comprising probes for Mycobacteria genotyping, M. tuberculosis strain differentiation and antibiotic-resistance detection

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073436A1 (en) * 1999-05-29 2000-12-07 Sj Hightech Co., Ltd. Oligonucleotide for detection and identification of mycobacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230305T2 (en) * 1991-08-15 2000-07-20 F. Hoffmann-La Roche Ag, Basel Pair of primers for the detection of Mycobacterium
FR2709310B1 (en) * 1993-07-23 1995-09-29 Bio Merieux Nucleotide fragment of 23S ribosomal RNA from mycobacteria, probes and primers, reagent and method of detection.
US5925518A (en) * 1995-05-19 1999-07-20 Akzo Nobel N.V. Nucleic acid primers for amplification of a mycobacteria RNA template

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073436A1 (en) * 1999-05-29 2000-12-07 Sj Hightech Co., Ltd. Oligonucleotide for detection and identification of mycobacteria

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] "Mycobacterium flavescens internal transcribed spacer, complete sequence", Database accession no. (AF191086) *
DATABASE GENBANK [online] "Mycobacterium fortuitum 16S-23S intergenic spacer region, complete sequence", Database accession no. (AF144326) *
HENDOLIN P.H. ET AL.: "Use of multiple PCR for simultaneous detection of four bacterial species in middle ear effusions", J. CLIN. MICROBIOL., vol. 35, no. 11, 1997, pages 2854 - 2858, XP002337154 *
WANG ET AL.: "A multiplex PCR for Massachusetts and Arkansas serotypes of infectious bronchitis virus", MOL. CEL. PROBES, vol. 13, no. 1, 1999, pages 1 - 7, XP004441531, DOI: doi:10.1006/mcpr.1998.0204 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080871A2 (en) 2002-03-26 2003-10-02 Hain Lifescience Gmbh Method for detection and differentiation of mycobacterium tuberculosis complex
WO2003080871A3 (en) * 2002-03-26 2004-02-05 Hain Lifescience Gmbh Method for detection and differentiation of mycobacterium tuberculosis complex
DE10215238C1 (en) * 2002-04-06 2003-08-14 Cytonet Gmbh & Co Kg Detecting mycobacteria and differentiating between Mycobacterium tuberculosis and Mycobacterium avium, comprises amplifying the 16S rRNA gene
EP1988176A1 (en) * 2002-12-19 2008-11-05 Tosoh Corporation Method of detecting acid-fast bacteria using ribosomal RNA as target
EP1431400A2 (en) * 2002-12-19 2004-06-23 Tosoh Corporation Method of detecting acid-fast bacteria using ribosomal RNA as target
AU2003288577B2 (en) * 2003-12-03 2011-06-02 Council Of Scientific And Industrial Research Method for detecting pathogenic mycobacteria in clinical specimens
WO2005056831A1 (en) * 2003-12-03 2005-06-23 Council Of Scientific And Industrial Research Method for detecting pathogenic mycobacteria in clinical specimens
US7332597B2 (en) 2004-06-28 2008-02-19 University Of Kentucky Research Foundation Primers and probe to identify mycobacterium tuberculosis complex
EP2270202A1 (en) * 2009-07-03 2011-01-05 John Ikonomopoulos Mycobacterial detection
JP2013502922A (en) * 2009-08-26 2013-01-31 エルジー ライフ サイエンス リミテッド M.M. A composition for detecting the M. TUBERCULOSIS group and the genus MYCOBACTERIA, and multiplex real-time PCR using the same composition, M. tuberculosis group. A method for simultaneously detecting the M. TUBERCULOSIS group and the genus MYCOBACTERIA
WO2014164094A1 (en) * 2013-03-11 2014-10-09 Kailos Genetics, Inc. Capture methodologies for circulating cell free dna
US9982255B2 (en) 2013-03-11 2018-05-29 Kailos Genetics, Inc. Capture methodologies for circulating cell free DNA
US11162094B2 (en) 2013-03-11 2021-11-02 Kailos Genetics, Inc. Capture methodologies for circulating cell free DNA
CN103555828A (en) * 2013-10-10 2014-02-05 上海市肺科医院 Rapid detection method and detection target for drug sensitivity of mycobacteria
CN103555828B (en) * 2013-10-10 2016-04-06 上海市肺科医院 Mycobacterium quick medicine-sensitive detection method and detection target
CN109975543A (en) * 2019-03-01 2019-07-05 中国疾病预防控制中心传染病预防控制所 The application of mycobacteria Ku albumen
CN109975543B (en) * 2019-03-01 2022-02-11 中国疾病预防控制中心传染病预防控制所 Application of mycobacterium Ku protein

Also Published As

Publication number Publication date
KR100433260B1 (en) 2004-05-24
AU2001278813A1 (en) 2002-03-26
KR20020021453A (en) 2002-03-21

Similar Documents

Publication Publication Date Title
CN102329880B (en) Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
Ross et al. Rapid, simple method for typing isolates of Mycobacterium tuberculosis by using the polymerase chain reaction
JP3070529B2 (en) Species-specific detection of Mycobacterium kansasii
EP0887425B1 (en) Multiplexed PCR assay for detecting disseminated mycobacterium avium complex infection
KR101802417B1 (en) A multiplex PCR primer set, a composition and a kit comprising the same for diagnosing Mycobacterium tuberculosis and non-tuberculous mycobacteria
WO2000073436A1 (en) Oligonucleotide for detection and identification of mycobacteria
KR100454585B1 (en) Microarray comprising probes for Mycobacteria genotyping, M. tuberculosis strain differentiation and antibiotic-resistance detection
Mijs et al. Evaluation of a commercial line probe assay for identification of Mycobacterium species from liquid and solid culture
WO2002022872A1 (en) Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method
WO2010062897A1 (en) Methods and compositions to detect clostridium difficile
JPH09248193A (en) Amplification and detection of mycobacterium avium complex species
EP0669402A2 (en) Nucleic acid sequences specific for mycobacterium kansasii
AU2003241562B9 (en) Molecular identification of Aspergillus species
WO2003008645A1 (en) A method for identifying mycobacterium tuberculosis and non-tuberculosis mycobacterium, together with detecting resistance to an antituberculosis drug of mycobacterium obtained by mutation of rpob gene
EP0760005B1 (en) Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping
Kurabachew et al. Amplified ribosomal DNA restriction analysis in the differentiation of related species of mycobacteria
Englund IS900/ERIC-PCR as a tool to distinguish Mycobacterium avium subsp. paratuberculosis from closely related mycobacteria
Glennon et al. Detection and diagnosis of mycobacterial pathogens using PCR
EP1711620B1 (en) Methods for detection of mycobacterium tuberculosis
KR100435587B1 (en) Primers for amplifying hsp 65 gene of mycobaterial specifes and method of identification of mycobaterial specifes with the same
KR100486820B1 (en) Hsp 65 gene fragments and method of identifying mycobaterial species with the same
Yamamoto et al. Polymerase chain reaction for the differentiation of Mycobacterium intracellulare and Mycobacterium avium
JP2003135099A (en) Method for identifying acid-fast bacterium by phylogenetic analysis
Rondini et al. Chapter VII: Genetic diversity in Mycobacterium ulcerans isolates from Ghana revealed by a newly identified locus containing a variable number of tandem repeats
KR20000075178A (en) sequence of ITS in M. fortuitum

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC FORM 1205A DATED OF 09-07-03

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP